FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791896641> ?p ?o ?g. }

• W2791896641 endingPage "1159" @default.
• W2791896641 startingPage "1149" @default.
• W2791896641 abstract "TopicTo estimate the prevalence of nonrefractive visual impairment and blindness in European persons 55 years of age and older.Clinical RelevanceFew visual impairment and blindness prevalence estimates are available for the European population. In addition, many of the data collected in European population-based studies currently are unpublished and have not been included in previous estimates.MethodsFourteen European population-based studies participating in the European Eye Epidemiology Consortium (n = 70 723) were included. Each study provided nonrefractive visual impairment and blindness prevalence estimates stratified by age (10-year strata) and gender. Nonrefractive visual impairment and blindness were defined as best-corrected visual acuity worse than 20/60 and 20/400 in the better eye, respectively. Using random effects meta-analysis, prevalence rates were estimated according to age, gender, geographical area, and period (1991–2006 and 2007–2012). Because no data were available for Central and Eastern Europe, population projections for numbers of affected people were estimated using Eurostat population estimates for European high-income countries in 2000 and 2010.ResultsThe age-standardized prevalence of nonrefractive visual impairment in people 55 years of age or older decreased from 2.22% (95% confidence interval [CI], 1.34–3.10) from 1991 through 2006 to 0.92% (95% CI, 0.42–1.42) from 2007 through 2012. It strongly increased with age in both periods (up to 15.69% and 4.39% in participants 85 years of age or older from 1991 through 2006 and from 2007 through 2012, respectively). Age-standardized prevalence of visual impairment tended to be higher in women than men from 1991 through 2006 (2.67% vs. 1.88%), but not from 2007 through 2012 (0.87% vs. 0.88%). No differences were observed between northern, western, and southern regions of Europe. The projected numbers of affected older inhabitants in European high-income countries decreased from 2.5 million affected individuals in 2000 to 1.2 million in 2010. Of those, 584 000 were blind in 2000, in comparison with 170 000 who were blind in 2010.ConclusionsDespite the increase in the European older population, our study indicated that the number of visually impaired people has decreased in European high-income countries in the last 20 years. This may be the result of major improvements in eye care and prevention, the decreasing prevalence of eye diseases, or both. To estimate the prevalence of nonrefractive visual impairment and blindness in European persons 55 years of age and older. Few visual impairment and blindness prevalence estimates are available for the European population. In addition, many of the data collected in European population-based studies currently are unpublished and have not been included in previous estimates. Fourteen European population-based studies participating in the European Eye Epidemiology Consortium (n = 70 723) were included. Each study provided nonrefractive visual impairment and blindness prevalence estimates stratified by age (10-year strata) and gender. Nonrefractive visual impairment and blindness were defined as best-corrected visual acuity worse than 20/60 and 20/400 in the better eye, respectively. Using random effects meta-analysis, prevalence rates were estimated according to age, gender, geographical area, and period (1991–2006 and 2007–2012). Because no data were available for Central and Eastern Europe, population projections for numbers of affected people were estimated using Eurostat population estimates for European high-income countries in 2000 and 2010. The age-standardized prevalence of nonrefractive visual impairment in people 55 years of age or older decreased from 2.22% (95% confidence interval [CI], 1.34–3.10) from 1991 through 2006 to 0.92% (95% CI, 0.42–1.42) from 2007 through 2012. It strongly increased with age in both periods (up to 15.69% and 4.39% in participants 85 years of age or older from 1991 through 2006 and from 2007 through 2012, respectively). Age-standardized prevalence of visual impairment tended to be higher in women than men from 1991 through 2006 (2.67% vs. 1.88%), but not from 2007 through 2012 (0.87% vs. 0.88%). No differences were observed between northern, western, and southern regions of Europe. The projected numbers of affected older inhabitants in European high-income countries decreased from 2.5 million affected individuals in 2000 to 1.2 million in 2010. Of those, 584 000 were blind in 2000, in comparison with 170 000 who were blind in 2010. Despite the increase in the European older population, our study indicated that the number of visually impaired people has decreased in European high-income countries in the last 20 years. This may be the result of major improvements in eye care and prevention, the decreasing prevalence of eye diseases, or both." @default.
• W2791896641 created "2018-03-29" @default.
• W2791896641 creator A5000893112 @default.
• W2791896641 creator A5001019451 @default.
• W2791896641 creator A5001073711 @default.
• W2791896641 creator A5002448265 @default.
• W2791896641 creator A5002705709 @default.
• W2791896641 creator A5002789667 @default.
• W2791896641 creator A5003574809 @default.
• W2791896641 creator A5006941006 @default.
• W2791896641 creator A5006959216 @default.
• W2791896641 creator A5008248296 @default.
• W2791896641 creator A5008535670 @default.
• W2791896641 creator A5009733412 @default.
• W2791896641 creator A5009918250 @default.
• W2791896641 creator A5010305198 @default.
• W2791896641 creator A5010618682 @default.
• W2791896641 creator A5010641221 @default.
• W2791896641 creator A5011166241 @default.
• W2791896641 creator A5012537661 @default.
• W2791896641 creator A5012848870 @default.
• W2791896641 creator A5016922490 @default.
• W2791896641 creator A5017026310 @default.
• W2791896641 creator A5017838181 @default.
• W2791896641 creator A5018056670 @default.
• W2791896641 creator A5018227698 @default.
• W2791896641 creator A5019521414 @default.
• W2791896641 creator A5020100288 @default.
• W2791896641 creator A5021882942 @default.
• W2791896641 creator A5022163792 @default.
• W2791896641 creator A5023026734 @default.
• W2791896641 creator A5024861911 @default.
• W2791896641 creator A5027512600 @default.
• W2791896641 creator A5027578520 @default.
• W2791896641 creator A5027679064 @default.
• W2791896641 creator A5028494756 @default.
• W2791896641 creator A5029097425 @default.
• W2791896641 creator A5029364514 @default.
• W2791896641 creator A5029426446 @default.
• W2791896641 creator A5029529953 @default.
• W2791896641 creator A5030017319 @default.
• W2791896641 creator A5031621118 @default.
• W2791896641 creator A5031702329 @default.
• W2791896641 creator A5031892617 @default.
• W2791896641 creator A5031999046 @default.
• W2791896641 creator A5032970955 @default.
• W2791896641 creator A5034780611 @default.
• W2791896641 creator A5036864107 @default.
• W2791896641 creator A5038413562 @default.
• W2791896641 creator A5038416949 @default.
• W2791896641 creator A5038968705 @default.
• W2791896641 creator A5040088384 @default.
• W2791896641 creator A5040508487 @default.
• W2791896641 creator A5041855356 @default.
• W2791896641 creator A5042801829 @default.
• W2791896641 creator A5042846135 @default.
• W2791896641 creator A5042899138 @default.
• W2791896641 creator A5044120519 @default.
• W2791896641 creator A5044722413 @default.
• W2791896641 creator A5046701227 @default.
• W2791896641 creator A5046936277 @default.
• W2791896641 creator A5047200171 @default.
• W2791896641 creator A5047562697 @default.
• W2791896641 creator A5047769891 @default.
• W2791896641 creator A5047837989 @default.
• W2791896641 creator A5048391596 @default.
• W2791896641 creator A5048563371 @default.
• W2791896641 creator A5048960834 @default.
• W2791896641 creator A5049234547 @default.
• W2791896641 creator A5049546593 @default.
• W2791896641 creator A5050862939 @default.
• W2791896641 creator A5052269759 @default.
• W2791896641 creator A5053271086 @default.
• W2791896641 creator A5053553303 @default.
• W2791896641 creator A5054487026 @default.
• W2791896641 creator A5056420757 @default.
• W2791896641 creator A5056428570 @default.
• W2791896641 creator A5056550009 @default.
• W2791896641 creator A5058245918 @default.
• W2791896641 creator A5059816211 @default.
• W2791896641 creator A5060449722 @default.
• W2791896641 creator A5060894655 @default.
• W2791896641 creator A5061223187 @default.
• W2791896641 creator A5061287178 @default.
• W2791896641 creator A5062277023 @default.
• W2791896641 creator A5062916198 @default.
• W2791896641 creator A5063516832 @default.
• W2791896641 creator A5064272918 @default.
• W2791896641 creator A5064732701 @default.
• W2791896641 creator A5065946805 @default.
• W2791896641 creator A5066789689 @default.
• W2791896641 creator A5067378573 @default.
• W2791896641 creator A5068708409 @default.
• W2791896641 creator A5071119636 @default.
• W2791896641 creator A5071283067 @default.
• W2791896641 creator A5072016106 @default.
• W2791896641 creator A5072407480 @default.
• W2791896641 creator A5072458761 @default.

• next